Published on in Vol 9, No 2 (2020): Apr-Jun
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/17863, first published
.
![Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study Health-Related Effects of Home Nebulization With Glycopyrronium on Difficult-to-Treat Asthma: Post-Hoc Analyses of an Observational Study](https://asset.jmir.pub/assets/01aa02be6f4a32d4d348177ea1f568d1.png 480w,https://asset.jmir.pub/assets/01aa02be6f4a32d4d348177ea1f568d1.png 960w,https://asset.jmir.pub/assets/01aa02be6f4a32d4d348177ea1f568d1.png 1920w,https://asset.jmir.pub/assets/01aa02be6f4a32d4d348177ea1f568d1.png 2500w)
Journals
- Albertson T, Pugashetti J, Chau-Etchepare F, Chenoweth J, Murin S. Pharmacotherapeutic management of asthma in the elderly patient. Expert Opinion on Pharmacotherapy 2020;21(16):1991 View
- Wei W, Chen W, He N. HDAC4 induces the development of asthma by increasing Slug-upregulated CXCL12 expression through KLF5 deacetylation. Journal of Translational Medicine 2021;19(1) View
- Mathis B, Kusumoto M, Zaboronok A, Hiramatsu Y. Packaging and Delivery of Asthma Therapeutics. Pharmaceutics 2021;14(1):92 View
- Pelaia C, Crimi C, Crimi N, Ricciardi L, Scichilone N, Valenti G, Bonavita O, Andaloro S, Morini P, Rizzi A, Pelaia G. Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma. Expert Review of Respiratory Medicine 2022;16(2):183 View